Abstract
Homocysteine (HC) and dehydroepiandrosterone sulphate (DHEAS) plasma levels have been evaluated in groups of male and female patients with Parkinson’s Disease (PD) and in a group of female patients with Alzheimer’s Disease (AD) and compared with the corresponding plasma levels observed in a group of age-matched subjects. It has been confirmed that HC plasma levels are enhanced in both PD and AD patients.
As far as the DHEAS plasma levels are concerned no changes have been observed in PD patients while a marked decrease has been observed in AD patients. These results support the view that while the pro-oxidant effects of HC and its agonist action at NMDA receptors can play a role in both neu-rodegenerative diseases, the role of DHEAS is more complex and may be an important factor only in certain neurodegenerative diseases. Thus, according to the present study DHEAS is likely to be involved in AD but not in PD.
Similar content being viewed by others
References
Agnati LF, S Genedani, G Rasio, M Galantucci, S Saltini, M Filaferro, R Franco, F Mora, S Ferrè and K Fuxe (2004, 12 May online) Studies on homocysteine plasma levels in Alzheimer’s patients, relevance for neurodegeneration.J. Neural Transm.
Agnati LF, D Guidolin, S Genedani, S Ferré, A Bigiani, A Woods and K Fuxe (submitted) How proteins come together in the plasma membrane and function in macromolecular assemblies: focus on receptor mosaics.J. Mol. Neurosci.
Aragno M, S Parola, E Tamagno, E Brignardello, R Manti, O Danni and G Boccuzzi (2000) Oxidative derangement in rat synapto-somes induced by hyperglycaemia: restorative effect of dehy-droepiandrosterone treatment.Biochem. Pharmacol. 60, 389–395.
Arlt W, F Callies and B Allolio (2000) DHEA replacement in women with adrenal insufficiency: pharmacokinetics, bioconver-sion and clinical effects on well-being, sexuality and cognition.Endocr. Res. 26, 505–511.
Asaba H, K Hosoya, H Takanaga, S Ohtsuki, E Tamura, T Takizawa and T Terasaki (2000) Blood-brain barrier is involved in the efflux transport of a neuroactive steroid, dehydroepiandrosterone sulfate, via organic anion transporting polypeptide 2.J. Neurochem. 75, 1907–1916.
Baulieu EE, P Robel and M Schumacher (1999)Neurosteroids, A New Regulatory Function in the Nervous System (Humana Press: Totawa, NJ, USA).
Baydas G, S Kutlu, M Naziroglu, S Canpolat, S Sandal, M Ozcan and H Kelestimur (2003) Inhibitory effects of melatonin on neural lipid peroxidation induced by intracerebroventricularly administered homocysteine.J. Pineal Res. 34, 36–39.
Bélanger N, L Grégoire, PJ Bédard and T Di Paolo (2003) Estradiol and dehydroepiandrosterone potentiate levodopa-induced loco-motor activity in 1-methyl-4-phenyl-,2,3,6-tetrahydropyridine monkeys.Endocrine 21, 97–101.
Brion JP (1998) Neurofibrillary tangles and Alzheimer’s disease.Eur. Neurol. 40, 130–140.
Broch OJ and PM Ueland (1984) Regional distribution of homo-cysteine in the mammalian brain.J. Neurochem. 43, 1755–1757.
Cardounel A, W Regelson and M Kalimi (1999) Dehydro-epiandrosterone protects hippocampal neurons against neurotox-in-induced cell death: mechanism of action.Proc. Soc. Exp. Biol. Med. 222, 145–149.
Clark S, LD Youngman, J Sullivan, R Peto and R Collins (2003) Stabilization of homocysteine in unseparated blood over several days: a solution for epidemiological studies.Clin. Chem. 49, 518–520.
Daniel WW (1999)Biostatistics: A Foundation for Analysis in the Health Sciences (John Wiley: New York NY, USA).
D’Astous M, M Morissette, B Tanguay, S Callier and T Di Paolo (2003) Dehydroepiandrosterone (DHEA) such as 17beta-estradi-ol prevents MPTP-induced dopamine depletion in mice.Synapse 47, 10–14.
Di Paolo T (1994) Modulation of brain dopamine transmission by sex steroids.Rev. Neurosci. 5, 27–41.
Flood JF and E Roberts (1988) Dehydroepiandrosterone sulphate improves memory in aging mice.Brain Res. 448, 178–181.
Fowler B (2001) Transport and tissue distribution of homocysteine and relatedS-adenosyl compounds, InHomocysteine in Health and Disease (Carmel R and DW Jacobsen, Eds.) Cambridge Univeristy Press: Cambridge), pp 163–175.
Fuxe K, K Andersson, R Schwarcz, LF Agnati, M Pérez de la Mora, T Hökfelt, M Goldstein, L Ferland, L Possani and R Tapia (1979) Studies on different types of dopamine nerve terminals in the forebrain and their possible interactions with hormones and with neurons containing GABA, glutamate and opioid peptides.Adv. Neurol. 24, 199–215.
Ho PI, D Ashline, S Dhitavat, D Ortiz, SC Collins, TB Shea and E Rogers (2003) Folate deprivation induces neurodegeneration: roles of oxidative stress and increased homocysteine.Neurobiol. Dis. 14, 32–42.
Hoehn MM and MD Yahr (1967) Parkinsonism: onset, progression and mortality.Neurology 17, 427–442.
Hyland K and T Bottiglieri (1992) Measurement of total plasma and cerebrospinal fluid homocysteine by fluorescence following high-performance liquid chromatography and precolumn deriva-tization witho-phthaldialdehyde.J. Chromatogr. 579, 55–62.
Jara-Prado A, A Ortega-Vazquez, L Martinez-Ruano, C Riosand and A Santamaria (2003) Homocysteine-induced brain lipid per-oxidation: effects of NMDA receptor blockade, antioxidant treatment, and nitric oxide synthase inhibition.Neurotox. Res. 5, 237–243.
Khalil A, JP Fortin, JG LeHoux and T Fulop (2000) Age-related decrease of dehydroepiandrosterone concentrations in low density lipoproteins and its role in the susceptibility of low density lipoproteins to lipid peroxidation.J. Lipid Res. 41, 1552–1561.
Kim SB, M Hill, YT Kwak, R Hampl, DH Jo and R Morfin (2003) Neurosteroids: cerebrospinal fluid levels for Alzheimer’s disease and vascular dementia diagnostics.J. Clin. Endocrinol. Metab. 88, 5199–5206.
Lipton SA, WK Kim, YB Choi, S Kumar, DM D’Emilia, PV Rayudu, DR Arnelle and JS Stamler (1997) Neurotoxicity associated with dual actions of homocysteine at theN-methyl-D-aspartate receptor.Proc. Natl. Acad. Sci. USA 94, 5923–5928.
Magni E, G Binetti, A Bianchetti, R Rozzini and M Trabucchi (1996) Mini-mental state examination: a normative study in italian elderly population.Eur. J. Neurol. 3, 1–5.
Mattson MP and TB Shea (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders.Trends Neurosci. 26, 137–146.
Maurice T, JL Junien and A Privat (1998) Sigma1 receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism.Neuroscience 83, 413–428.
Mazat L, S Lafon, B Debuire, JF Tessier, JF Dartigues and EE Baulieu (2001) Prospective measurements of dehydroepiandros-terone sulfate in a cohort of elderly subjects: relationship, to gender, subjective health, smoking habits, and 10-year mortality.Proc. Natl. Acad. Sci. USA 98, 8145–8150.
Miller JW, J Selhub, MR Nadeau, CA Thomas, RG Feldman and PA Wolf (2003) Effect of l-dopa on plasma homocysteine in PD patients:relationship to B-vitamin status.Neurology 60, 1125–1129.
Pfeiffer CM, DL Huff and EW Gunter (1999) Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting.Clin. Chem. 45, 290–292.
Rasmuson S, B Bnasman, K Carlstrom and T Olsson (2002) Increased levels of adrenocortical and gonadal hormones in mild to moderate Alzheimer’s disease.Dement. Geriatr. Cogn. Disord. 13, 74–79.
Razani B, SE Woodman and MP Lisanti (2002) Caveolae: from cell biology to animal physiology.Pharmacol. Rev. 54, 431–467.
Roberts E (1999) The importance of being dehyroepiandrosterone sulfate (in the blood of primates). A longer and healthier life?Biochem. Pharmacol. 57, 329–346.
Rosenfeld RS, L Hellman and T Gallagher (1972) Metabolism and interconversion of DHEA and DHEA-S.J. Clin. End. Metab. 35, 187–193.
Schumacher M, S Weill-Engerer, P Liere, F Robert, RJM Franklin, LM Garcia-Segura, JJ Lambert, W Mayo, RC Melcangi, A Parducz, U Suter, C Carelli, EE Baulieu and Y Akwa (2003) Steroid hormones and neurosteroids in normal and pathological aging of the nervous system.Prog. Neurobiol. 71, 3–29.
Seshadri S, A Beiser, J Selhub, PF Jacques, IH Rosenberg, RB D’Agostino, PW Wilson and PA Wolf (2002) Plasma homocys-teine as a risk factor for dementia and Alzheimer’s disease.New Engl. J. Med. 346, 476–483.
Simons K and E Ikonen (1997) Functional rafts in cell membranes.Nature 387, 569–572.
Wang M, G Wahlström and T Bäckström (1977) The regional brain distribution of the neurosteroids pregnenolone and preg-nenolone sulfate following intravenous infusion.J. Steroid. Mol. Biol. 62, 299–306.
Weill-Engerer S, JP David, V Sazdovitch, P Liere, B Eychenne, A Pianos, M Shumacher, A Delacourte, EE Baulieu and Y Akwa (2002) Neurosteroids quantification in human brain regions: comparison between Alzheimer’s and nondemented patients.J. Clin. Endocrinol. Metab.. 87, 5138–5143.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Genedani, S., Rasio, G., Cortelli, P. et al. Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in alzheimer’s disease patients and in Parkinson’s disease patients. neurotox res 6, 327–332 (2004). https://doi.org/10.1007/BF03033443
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF03033443